FundedIQ
Health Care

Notable Systems

Notable Systems offers a health data platform that aims to revolutionize healthcare IT by making health data input and access more user-friendly. Their platform allows for easy data entry, passive data collection, seamless data access across various systems and organizations, and integration of different products via open API. This helps healthcare organizations efficiently capture and access health data.

notablesystems.com/about Denver, United States 11-50 employees
Total raised
$12.0M
Rounds
2
Latest
Series B
Aug 2026

Notable Systems offers a health data platform that aims to revolutionize healthcare IT by making health data input and access more user-friendly. Their platform allows for easy data entry, passive data collection, seamless data access across various systems and organizations, and integration of different products via open API. This helps healthcare organizations efficiently capture and access health data.

Notable Systems has raised $12.0M across 2 rounds. Its most recent round was a Series B in Aug 2026. Full funding history, investors, and team are detailed below.

Funding history

2 rounds · 1 visible Unlock with FundedIQ

2 rounds on record — latest round shown, the rest open on a FundedIQ plan.

Date
Round
Amount
Lead investor
Aug 10, 2026
Series B
Undisclosed

Unlock 1 earlier round — dates, amounts, round types — plus the lead investor for every round.

Start 14-day free trial →

People

Unlock with FundedIQ

Founders, executives, and decision-makers — sourced and refreshed weekly.

Name
Role
LinkedIn

See who runs this company — founders and key execs, with titles, verified email addresses and LinkedIn profiles.

Start 14-day free trial →

Notable Systems is featured in

Similar companies

Teal Health

Teal Health is on a mission to empower women when it comes to their health – starting with at-home cervical cancer screenings. We believe that it’s time for women’s health to be designed for women, their preferences, and their experiences. With this in mind, Teal Health is creating the first FDA-approved at-home cervical cancer screening making it simple for a woman to stay current on this life-saving screening from the comfort, convenience, and privacy of her home. Through timely screenings, Teal health plans to eradicate cervical cancer in the US. Teal is backed by passionate and committed investors who share this important vision, including Felicis Ventures, Emerson Collective, Metrodora, and Serena Ventures.

Series A $18.3M
Livingston Hospital and Healthcare Services

Livingston Hospital and Healthcare Services Provide personalized, high-quality healthcare, responsive to the needs of the community.

Private Equity $5.0M
Theradaptive

Theradaptive is a clinical-stage biologics company that is privately held and focused on developing protein therapeutics for spine, orthopedics, soft tissue repair, and targeted immuno-oncology. The company's innovative platform converts recombinant proteins into material-binding variants that can be used to coat implants, devices, and injectable carriers for various medical treatments. Theradaptive's lead candidate, OsteoAdapt SP™, is currently being evaluated in a Phase I/II clinical trial for degenerative disc disease, a condition that causes spinal joint deterioration and pain. This candidate combines Theradaptive's engineered protein AMP2™ with a synthetic bone graft to address this challenging medical issue.

Series Unknown $36.2M
Function Health

100 Healthy Years • Your new routine of 120+ advanced lab tests explained by the world's top doctors

Private Equity $450M
Sound Health

Sound Health utilizes acoustic resonance to offer relief for nasal issues. Their current offering is an app which scans the face to create a map of the bone structure, along with a headband that emits personalized frequencies for a 10-minute duration. The headband is readily available and the sound levels are comparable to using earbuds. The goal is for the headband to be easily attainable without a prescription, for the convenience of all patients.

Series A
Throne

Throne is a health company that focuses on individual gut wellness and hydration maintenance.

Series A $10.0M
Holobiome

Holobiome is a company that specializes in developing therapies for diseases affecting the enteric and central nervous systems. Using microbiome-based treatments, the company aims to address a range of mental health issues, as well as metabolism and immune responses. Founded in 2015, Holobiome is located in Cambridge, Massachusetts.

Seed $10.0M
CurieDx

CurieDx is the image-based diagnostics using a smartphone photograph, they assist patients in recovering more quickly.

Seed $200k
Estrigenix Therapeutics

Estrigenix Therapeutics, Inc. is a non-public pharmaceutical company with a goal of creating ground-breaking medications to enhance the mental well-being of women experiencing menopause. Inaugurated in 2018, Estrigenix Therapeutics aims to enhance women's health, starting with addressing the physical and psychological impacts of menopause.

Seed $2.0M
Firsthand

Firsthand knowledge of severe mental illness, in our opinion, ought to be valued more. Our founding group of healthcare experts and serial entrepreneurs have purposefully devoted their professional lives to assisting marginalised individuals with serious mental illnesses in collaboration with local nonprofits. We are actively expanding our team with like-minded business creators.

Series Unknown $10.0M
Karoo Health

Karoo Health is a leader in tech-enabled value-based cardiovascular care solutions and aims to bring innovative, end-to-end, cardiovascular solutions to patients via partnerships with health plans and self-insured employers. As a patient-first organization, Karoo Health’s mission is to help patients lead their best lives by providing a new paradigm of better cardiology care, at lower cost, than the current system and preventing the progression of cardiovascular disease.

Series A $16.2M
410 Medical

A medical device firm called 410 Medical is committed to creating cutting-edge technologies that help doctors provide better treatment for seriously ill patients. The recently approved LifeFlow® PLUS device from 410 is intended to increase the speed and effectiveness of volume resuscitation, enhancing the treatment of patients with life-threatening illnesses such sepsis, bleeding, and cardiac arrest.

Series Unknown $12.0M
14-day free trial · Cancel anytime

Know who just raised. Then know who to call.

Every newly funded startup with its round, its investors, and its founders — delivered weekly, or searchable back to 2020.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.